The cold, flu, and immunity supplement market skyrocketed in 2020, but should the pullback in 2021 and 2022 be worrisome or is the future bright for the category? The “COVID-19 Effect” undoubtedly pulled forward the demand for products a few years (which has now normalized), but this period more importantly changed consumer perception around immune health. That shift from only supporting your immune health seasonally to now making it a year-round pursuit is a big deal. Maybe the legacy immune ingredients with high consumer awareness or played out formulation approaches won’t see massive sales surges again in the near-term future and that’s OK. But it’s the massive wave of attention placed on immune health and investment put towards innovation that will open new opportunities…that’s exciting to think about and I predict it will provide strong categorical market growth.